Medisca's Hair Care Compounding Solutions

Download in electronic PDF format for $25

Search the Complete Journal Archives

Basics of Compounding for Hazardous Drugs, Part 1: An Introduction

Author(s):  Allen Loyd V Jr

Issue:  Sep/Oct 2006 - Dermatology
View All Articles in Issue

Abstract:  National Institute of Occupational Safety and Health Publication No. 2004–165, Preventing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in Health Care Settings, was published in 2004 to increase the awareness of healthcare workers and other professionals about the health risks of working with hazardous drugs and to provide measures for protecting their health. The health risks to employees who prepare or administer hazardous drugs in the workplace is influenced by many factors, and each compounding facility is responsible for developing its own list of hazardous drugs and for creating standard operating procedures to reduce risks as much as possible for employees. To provide employees with the greatest protection, employers should (1) implement necessary administrative and engineering controls, and (2) assure that the workers use sound procedures and proper protective equipment for handling hazardous drugs.

Related Keywords: Loyd V. Allen Jr., PhD, RPh, USP, hazardous drugs, cytotoxic drugs, chemotherapy, workplace safety

Related Categories: BUSINESS, LEGAL, SUPPORT

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Basics of Compounding for the Treatment of Warts Allen Loyd V Jr Mar/Apr 2004 126 Buy
Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination Allen Loyd V Jr Nov/Dec 2006 446-448 Buy
Basics of Compounding for Hazardous Drugs, Part 1: An Introduction Allen Loyd V Jr Sep/Oct 2006 377-379 Buy
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr Nov/Dec 2003 449-450 Buy
Roboticized Compounding of Oncology Drugs in a Hospital Pharmacy Palma Elisabetta, Bufarini Celestino Sep/Oct 2014 358-364 Buy
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs Allen Loyd V Jr, Okeke Claudia C Jan/Feb 2009 56-62 Buy
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr Jul/Aug 2016 351 View Sample
Compounding Using Hazardous Drugs Lau Kellie Jul/Aug 2000 261 Buy
The US FDA List of Drugs Not to Be Used in Compounded Medications for Humans (the "Negative List") Allen Loyd V Jr, Ashworth Lisa D Jan/Feb 2005 44-46 Buy
Does Your Drug Expertise Include Clinical Pharmaceutics? Newton David W May/Jun 2016 202-206 Buy